Teva Pharmaceutical Industries
TEVA
#713
Rank
โ‚ฌ28.04 B
Marketcap
24,44ย โ‚ฌ
Share price
0.18%
Change (1 day)
49.31%
Change (1 year)

Revenue for Teva Pharmaceutical Industries (TEVA)

Revenue in 2025 (TTM): โ‚ฌ15.02 Billion

According to Teva Pharmaceutical Industries's latest financial reports the company's current revenue (TTM ) is โ‚ฌ14.40 Billion. In 2024 the company made a revenue of โ‚ฌ15.89 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ14.33 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Teva Pharmaceutical Industries from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ15.02 B-5.51%
2024 โ‚ฌ15.89 B10.9%
2023 โ‚ฌ14.33 B3.03%
2022 โ‚ฌ13.91 B-0.77%
2021 โ‚ฌ14.02 B3.53%
2020 โ‚ฌ13.54 B-7.54%
2019 โ‚ฌ14.64 B-11.13%
2018 โ‚ฌ16.48 B-11.9%
2017 โ‚ฌ18.70 B-10.16%
2016 โ‚ฌ20.82 B15.86%
2015 โ‚ฌ17.97 B7.83%
2014 โ‚ฌ16.66 B13.32%
2013 โ‚ฌ14.70 B-4.23%
2012 โ‚ฌ15.35 B8.93%
2011 โ‚ฌ14.10 B16.34%
2010 โ‚ฌ12.11 B24.93%
2009 โ‚ฌ9.70 B22.35%
2008 โ‚ฌ7.92 B23.06%
2007 โ‚ฌ6.44 B1.11%
2006 โ‚ฌ6.37 B43.78%
2005 โ‚ฌ4.43 B25.29%
2004 โ‚ฌ3.53 B35.94%
2003 โ‚ฌ2.60 B8.01%
2002 โ‚ฌ2.40 B2.43%
2001 โ‚ฌ2.35 B26.63%
2000 โ‚ฌ1.85 B45.75%
1999 โ‚ฌ1.27 B35.52%
1998 โ‚ฌ0.94 B-0.09%
1997 โ‚ฌ0.94 B17.1%
1996 โ‚ฌ0.80 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚ฌ48.41 B 236.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ40.81 B 183.29%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
โ‚ฌ36.37 B 152.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ53.92 B 274.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.17 B 282.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
โ‚ฌ3.39 B-76.41%๐Ÿ‡ฎ๐Ÿ‡ณ India
AstraZeneca
AZN
โ‚ฌ49.92 B 246.49%๐Ÿ‡ฌ๐Ÿ‡ง UK